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Summary: The primary objective of this systematic review was to address the 
question, “Are drivers with diabetes mellitus at greater risk for a motor vehicle 
crash than comparable drivers without the disease?” and secondarily, to address 
the question, “Are insulin-treated diabetics at higher risk for crash?” Our searches 
identified 16 articles that addressed these questions. An assessment of study 
quality of the included studies found them to be in the low-to-moderate range. 
While attempts were made to control for differences in the characteristics of 
individuals that may confound the relationship between diabetes and crash risk in 
all included studies, most failed to control for exposure. A random-effects meta-
analysis found that individuals with diabetes have a 19% increased risk for a 
motor vehicle crash when compared to similar individuals without diabetes. We 
found no compelling evidence to suggest that insulin-treated individuals are at 
higher risk for motor vehicle crash than individuals with diabetes not being 
treated with insulin. We discuss the implications of these findings. 
 
INTRODUCTION 
 
It is widely held that individuals with diabetes, particularly insulin-treated diabetics, are at higher 
risk of crash while driving. This view stems in large part from the well-known acute disabling 
effects of the disease (e.g., hypoglycemia), as well as longer term health complications (e.g., 
retinopathy, cardiovascular complications, and neuropathy). While this view is strongly 
maintained, the supporting evidence is limited. The primary objective of this systematic review 
was to address the question, “Are drivers with diabetes mellitus at greater risk for a motor 
vehicle crash than comparable drivers without the disease?” and secondarily, to address the 
question, “Are insulin-treated diabetics at higher risk for crash?” 
 
METHODS 
 
This systematic review followed the protocol outlined by Treadwell et al. (2006). Sensitive 
search strategies, developed and refined by an information specialist, were applied to the 
following seven electronic databases—Medline, PubMed (pre Medline), EMBASE, PSYCH 
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Info, CINAHL, TRIS, and the Cochrane Library (through May 28, 2006). Additional hand 
searches of the published literature (i.e., bibliographies of identified relevant articles) and “gray 
literature” resources (e.g., Web searches) were also performed. Formal a priori criteria for article 
retrieval and study inclusion consisted of: (1) English language publications, (2) full-length 
articles, (3) controlled (case-control or cohort) study design, and (4) enrolled ≥10 patients.  
 
The quality of all included studies was determined using a revised version of the 
Newcastle/Ottawa Scale (Wells, 2000). Random- and fixed-effects meta-analyses were used to 
pool data from different studies (Hedges, 1994; Raudenbush, 1994). The Q-statistic and I2 were 
used to identify heterogeneity among the studies’ results (Higgins, 2003). Sensitivity analyses, 
aimed at testing the robustness of our findings, included the use of cumulative fixed- and 
random-effects meta-analysis (Sterne, 1998). Publication bias was tested for using the “trim and 
fill” method with funnel plots (Duval & Tweedie, 2000). 
 
RESULTS 
 
Evidence Base 
 
Our searches identified a total of 159 potentially relevant articles, of which 16 were found to 
meet all inclusion criteria (Table 1). These 16 studies (describing unique datasets) addressed the 
following key questions:  
1) What is the risk ratio for a motor vehicle crash among drivers with diabetes compared to 
drivers without diabetes (13 studies)?  
2) Are drivers with diabetes overrepresented among drivers who have had a crash (3 studies)?  
In this review we focus on data extracted and combined from the first group of studies and 
supplement our findings with data from the smaller data set.  
 
Quality of Evidence Base 
 
An assessment of study quality using a validated instrument designed for assessing the quality of 
case-control and cohort studies found the quality of the included studies to be low-to-moderate 
(Table 2). Attempts were made by study investigators of all studies to control for differences in 
the characteristics of individuals that may confound the relationship between diabetes and crash 
risk. However, the majority of included studies failed to control for exposure. 
 
Generalizability of Evidence Base 
 
One included study (Laberge-Nadeau, 2000) enrolled commercial motor vehicle (CMV) drivers 
only; the remainder enrolled individuals with a private motor vehicle license. Individuals 
enrolled in the included studies comprised mixed populations; the majority of studies included 
individuals with both Type 1 and Type 2 diabetes. Only two studies constricted enrollment to 
individuals with Type 1 diabetes (Eadington & Frier, 1989; Songer, 1988). 
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Table 1. Evidence base 
Reference 
Year 
Study Design 
Com
parison 
Driving exposure 
controlled for? 
Prim
ary outcom
e 
Definition of 
crash 
Outcom
e self-
reported? 
Studies comparing crash rates among individuals with diabetes and individuals without the disorder (primary data set) 
Cox et al. 2003 CCS 673 individuals with diabetes vs. 
363 without diabetes 
Yes Difference in crash rate Driver in any motor 
vehicle crash  
Yes 
Laberge-Nadeau et 
al. 
2000 CCS 4,495 individuals with diabetes vs. 
8,958 without diabetes 
Yes Difference in crash rate CMV driver in any 
motor vehicle crash 
No  (provincial records) 
de Klerk & 
Armstrong 
1983 CCS 8,623 individuals with diabetes vs. 
expected rate (Western Australia) 
No Difference in crash rate Driver in injurious 
motor vehicle crash 
No  (hospital records) 
Hansotia & Broste  1991 CCS 484 individuals with diabetes vs. 
30,420 without diabetes 
No Difference in crash rate Driver in any motor 
vehicle crash 
No  (State Records) 
Stevens et al.  1989 CCS 354 individuals with diabetes vs. 
307 without diabetes 
No Difference in crash rate Driver in any motor 
vehicle crash 
Yes 
Eadington & Frier  1989 CCS 187 individuals with diabetes vs. 
data obtained from DOT and 
insurance claims 
No Difference in crash rate Driver in any motor 
vehicle crash 
Yes 
Songer et al.  1988 CCS 127 individuals with diabetes vs. 
127 without diabetes 
Yes Difference in crash rate Driver in any motor 
vehicle crash 
Yes 
Davis et al.  1973 CCS 108 individuals with diabetes vs. 
1,650,245 without diabetes 
No Difference in crash rate Driver in any motor 
vehicle crash 
No  (state records) 
Ysander  1970 CCS 219 individuals with diabetes vs. 
219 without diabetes 
No Difference in crash rate Driver in any motor 
vehicle crash 
No  (state records) 
Campbell & Ellis  1969 CCS 346 individuals with diabetes vs. 
346 without diabetes 
No Difference in crash rate Driver in any motor 
vehicle crash 
No  (provincial records) 
McMurray & 
Crancer 
1968 CCS 7,646 individuals with diabetes vs. 
1,600,000 without diabetes 
No Difference in crash rate Driver in any motor 
vehicle crash 
No  (state records) 
Ysander  1966 CCS 256 individuals with diabetes vs. 
256 without diabetes 
No Difference in crash rate Driver in injurious 
motor vehicle crash 
No  (government records) 
Waller 1965 CCS 287 individuals with diabetes vs. 
922 without diabetes 
No Difference in crash rate Driver in any motor 
vehicle crash 
No  (state records) 
Studies comparing prevalence of diabetes among crashers and non-crashers (secondary data set) 
McGwin et al.  1999 CCS 249 individuals at-fault crash vs. 
454 individuals no-crash 
Yes Difference in % of 
individuals with diabetes 
Driver in at-fault 
crash 
Yes  (telephone 
questionnaire) 
Gressert & Meyer  1994 CCS 1,400 individuals injurious crash vs. 
2,636 individuals no-crash 
Yes Difference in % of 
individuals with diabetes 
Driver in injurious 
motor vehicle crash 
No  (provincial records) 
Koepsell et al. 1994 CCS 234 individuals injured in crash vs. 
446 not involved in crash 
Yes Difference in % of 
individuals with diabetes 
Driver in injurious 
motor vehicle crash 
No  (health insurance 
and police records) 
CCS=case-control study 
 
RESULTS 
 
Data from the 13 studies that compared crash risk in drivers with diabetes to comparable drivers 
without the disease were found to be homogeneous (I2=13.9%; Q=18.2, P=0.1110). This finding 
suggests that the differences in the design, conduct, and populations used for these studies had 
little impact on outcome. A fixed effects meta-analysis (Figure 1) showed that individuals with 
diabetes are at a significantly increased risk for a motor vehicle crash (RR=1.19, 95% CI: 1.08–
1.32). In other words, the crash risk for diabetic drivers is 1.19 times greater than the risk for 
comparable drivers without diabetes. A series of sensitivity analyses found this finding to be 
robust with none of these analyses overturning the findings of the original analysis. No evidence 
of publication bias was found.  
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Table 2. Quality of evidence base 
Reference Year Quality Scale Used Quality Score Quality 
Studies comparing crash rates among individuals with diabetes and individuals without the disorder (primary data set) 
Cox et al. 2003 Revised Newcastle-Ottawa Quality Assessment Scale 8.5 Moderate 
Laberge-Nadeau et al. 2000 Revised Newcastle-Ottawa Quality Assessment Scale 9.4 Moderate 
de Klerk & Armstrong 1983 Revised Newcastle-Ottawa Quality Assessment Scale 6.3 Low 
Hansotia & Broste 1991 Revised Newcastle-Ottawa Quality Assessment Scale 5.4 Low 
Stevens et al. 1989 Revised Newcastle-Ottawa Quality Assessment Scale 7.0 Low 
Eadington & Frier 1989 Revised Newcastle-Ottawa Quality Assessment Scale 7.7 Low 
Songer et al. 1988 Revised Newcastle-Ottawa Quality Assessment Scale 7.9 Low 
Davis et al. 1973 Revised Newcastle-Ottawa Quality Assessment Scale 5.8 Low 
Ysander et al. 1970 Revised Newcastle-Ottawa Quality Assessment Scale 8.1 Moderate 
Campbell & Ellis 1969 Revised Newcastle-Ottawa Quality Assessment Scale 6.5 Low 
McMurray & Crancer 1968 Revised Newcastle-Ottawa Quality Assessment Scale 4.2 Low 
Ysander 1966 Revised Newcastle-Ottawa Quality Assessment Scale 7.1 Low 
Waller 1965 Revised Newcastle-Ottawa Quality Assessment Scale 7.1 Low 
Studies comparing prevalence of diabetes among crashers and non-crashers (secondary data set) 
McGwin et al. 1999 Revised Newcastle-Ottawa Quality Assessment Scale 10.0 Moderate 
Gressert & Meyer 1994 Revised Newcastle-Ottawa Quality Assessment Scale 7.8 Low 
Koepsell et al. 1994 Revised Newcastle-Ottawa Quality Assessment Scale 9.4 Moderate 
 
 
 
Study name Statistics for each study Rate ratio and 95% CI
Rate Lower Upper 
ratio limit limit Z-Value p-Value
Cox 1.954 0.796 4.798 1.462 0.144
Laberge-Nadeau 1.073 0.882 1.305 0.700 0.484
De Klerk 1.522 0.845 2.740 1.400 0.162
Hansotia 1.323 1.088 1.610 2.800 0.005
Stevens 0.932 0.664 1.309 -0.404 0.686
Eadington 0.538 0.198 1.461 -1.216 0.224
Songer 2.664 0.796 8.919 1.590 0.112
Davis 1.041 0.369 2.936 0.076 0.940
Ysander (1970) 0.583 0.254 1.338 -1.273 0.203
Campbell 1.716 1.160 2.540 2.700 0.007
Crancer 1.185 0.974 1.442 1.700 0.089
Ysander (1966) 0.651 0.170 2.493 -0.627 0.531
Waller 1.786 0.760 4.197 1.331 0.183
1.194 1.082 1.318 3.537 0.000
0.1 0.2 0.5 1 2 5 10
Reduced Risk Increased Risk  
Figure 1. Crash risk in drivers with diabetes  
relative to drivers without diabetes 
 
Having determined that drivers with diabetes are at an elevated risk for a motor vehicle crash, we 
next attempted to determine whether there were any specific subgroups of drivers with diabetes 
who were at greater risk for crash. In particular, we were interested in determining whether 
insulin-treated diabetic drivers were at a higher risk than individuals treated using either oral 
hypoglycemic agents or diet alone. The primary risk factor for a crash among individuals with 
diabetes is traditionally thought to be hypoglycemia. As there is a reasonably large body of 
literature showing that hypoglycemia occurs more often among individuals treated with insulin 
than among those treated by pharmacotherapy or diet alone, one might reasonably expect to 
observe that individuals with insulin-treated diabetes are at higher risk for a motor vehicle crash 
when compared with individuals who control their diabetes by other means. Five of the 13 
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included studies provided separate crash risk data for drivers who were insulin-treated (Cox, 
2003; Eadington & Frier, 1989; Laberge-Nadeau, 2000; Songer, 1988; Stevens, 1989) allowing 
us to estimate of the risk ratio associated with this subpopulation of drivers. 
 
Included among the five studies cited above was the study of Laberge-Nadeau et al. (2000). This 
study specifically assessed crash risk among CMV drivers with diabetes. In so doing, these 
investigators presented data separately for articulated and straight truck drivers. Making an 
assumption that the latter two data sets can be considered independent of one another (although 
sampled from the same database, the two groups consist of a different set of cases and controls), 
we treated them as if they were two separate studies. Consequently, a total of six data sets 
containing information on crash risk among drivers with insulin-dependent diabetes were 
available for analysis. These data were found to be heterogeneous (I2=68.97%; Q=16.11, 
P=0.0065). Data from a heterogeneous data set cannot be combined in a fixed-effects meta-
analysis because such a synthesis is in violation of the model’s underlying assumption of 
homogeneity. Instead, we pooled the available risk-ratio data using random-effects meta-
analysis, which allows one to combine heterogeneous data by partitioning the estimated 
between-studies variance component and adding it to the within-studies variance of each 
included study (Raudenbush, 1994). 
 
The results of this meta-analysis, which is presented in Figure 2, does not provide evidence 
supporting the contention that the risk for a motor vehicle crash is significantly higher among 
individuals with insulin-treated diabetes(RR=1.11, 95% CI: 0.80–1.80, P=0.676). Likewise, 
separate meta-analyses of subsets of data from three studies that compared the odds of having 
diabetes among a group of individuals who experienced a crash, with the odds of having diabetes 
among individuals who did not crash, failed to demonstrate that individuals with insulin-treated 
diabetes represent a population who are at higher risk for crash (Figure 3). 
 
Study name Statistics for each study Rate ratio and 95% CI
Rate Lower Upper 
ratio limit limit Z-Value p-Value
Cox 2.387 1.421 4.009 3.288 0.001
Laberge-Nadeau (AT) 0.651 0.350 1.209 -1.360 0.174
Laberge-Nadeau (ST) 1.020 0.444 2.343 0.047 0.962
Stevens 0.932 0.664 1.309 -0.404 0.686
Eadington 0.538 0.198 1.461 -1.216 0.224
Songer 2.664 0.796 8.919 1.590 0.112
1.111 0.683 1.808 0.424 0.672
0.1 0.2 0.5 1 2 5 10
Reduced Risk Increased Risk  
Figure 2. Random effects meta-analysis of crash data from insulin-treated cohorts 
 
DISCUSSION 
 
Drivers with diabetes mellitus are at 19 percent greater risk for a motor vehicle crash than drivers 
who do not have diabetes. This is important from a public policy perspective because diabetes is 
a highly prevalent condition with approximately 29 million people or 14.4% of those over 20 
years old with diagnosed diabetes, undiagnosed diabetes, or impaired fasting glucose (Centers 
for Disease Control and Prevention [CDC], 2003). 
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Study name Subgroup within study Statistics for each study Odds ratio and 95% CI
Odds Lower Upper 
ratio limit limit p-Value
Koepsell (diet) Diet 0.896 0.336 2.387 0.826
McGwin (diet) Diet 0.600 0.164 2.204 0.442
0.775 0.354 1.695 0.523
Koepsell (insulin) Insulin 5.812 1.168 28.913 0.032
Gressert (Insulin) Insulin 1.127 0.626 2.030 0.689
McGwin (insulin) Insulin 1.297 0.578 2.910 0.528
1.346 0.853 2.123 0.202
Koepsell (oral hypos) Oral hypos 3.096 0.869 11.025 0.081
McGwin (oral hypos) Oral hypos 1.297 0.772 2.178 0.326
1.469 0.909 2.374 0.117
Gressert (others) Oral or Diet 0.990 0.750 1.306 0.944
0.990 0.750 1.306 0.944
Koepsell (all) Overall 2.612 1.451 4.702 0.001
Gressert (all) Overall 1.105 0.908 1.344 0.317
McGwin (all) Overall 1.105 0.635 1.924 0.724
1.194 1.001 1.424 0.049
0.01 0.1 1 10 100
Reduced Risk Increased Risk  
Figure 3. Results of analyses of data from studies of prevalence  
of diabetes among crashers and non-crashers 
 
Drivers with diabetes are a heterogeneous group with a variety of potential mechanisms that 
could increase crash risk, in association with both acute and chronic medical complications of 
diabetes. The critical task is to identify subsets of drivers with diabetes who are at greatest risk 
for a crash. One such subset that might be suspected of having an increased crash risk is those 
who are subject to hypoglycemia, a potentially debilitating condition that affects both individuals 
with Type 1 and Type 2 diabetes. It is believed that insulin treated individuals (all those with 
Type 1 diabetes and a minority of those with Type 2 diabetes) are at an increased risk for 
hyperglycemia and hence, crash. Our analyses found no statistically significant evidence to 
suggest that insulin-treated individuals represent a higher risk subgroup of individuals with 
diabetes. However, because of the small size of the evidence base (low power) and the 
possibility that the insulin-treated individuals in the included studies are not representative of all 
insulin-treated individuals who drive, one cannot construe this finding as providing conclusive 
evidence that individuals with insulin-treated diabetes are not at greater risk for a crash than non-
insulin treated individuals. 
 
The findings of this review underscore the need for additional quality research on driving 
performance, safety errors, vehicle crashes, and countermeasures in drivers with different 
complications of diabetes. Relevant research can address driving safety issues related to 
problems of: 1) vision (e.g., diabetic retinopathy affecting acuity, contrast sensitivity and fields); 
2) cognition (e.g., attention, perception, memory and executive function), mood and arousal due 
to metabolic encephalopathy (e.g., with glucose shifts or renal disease) or cerebrovascular 
disease; 3) cardiac and peripheral vascular disease; 4) neuropathy (with numbness and weakness 
affecting control over the pedals); 5) side-effects of medicines; and 6) reduced self-awareness of 
physiologic and performance impairments caused by these factors.  
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